JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Volkow, N. D.
Right arrow Articles by Pappas, N. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Volkow, N. D.
Right arrow Articles by Pappas, N. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DOPAMINE
*METHYLPHENIDATE

Vol. 291, Issue 1, 409-415, October 1999

Reinforcing Effects of Psychostimulants in Humans Are Associated with Increases in Brain Dopamine and Occupancy of D2 Receptors1

Nora D. Volkow , Gene-Jack Wang, Joanna S. Fowler, Jean Logan, S. John Gatley, Cristopher Wong, Robert Hitzemann and Naomi R. Pappas

Brookhaven National Laboratory, Upton (N.D.V., G.-J.W., J.S.F., J.L., S.J.G., C.W., N.R.P.); Department of Psychiatry, State University of New York at Stony Brook, Stony Brook (N.D.V., R.H.), New York.

Increases in dopamine concentration in limbic brain regions have been postulated to underlie the reinforcing effects of psychostimulant drugs in laboratory animals. However, neither the qualitative nor the quantitative relationship between drug-induced increases in brain dopamine and the reinforcing effects of psychostimulant drugs have been investigated in humans. Positron emission tomograph and [11C]raclopride, a dopamine D2 receptor radioligand that competes with endogenous dopamine for occupancy of the D2 receptors, were used to measure changes in brain dopamine after different doses of i.v. methylphenidate in 14 healthy controls. In parallel, measures for self-reports of drug effects were obtained to assess their relationship to methylphenidate-induced changes in brain dopamine. The intensity of the "high" induced by methylphenidate was significantly correlated with the levels of released dopamine (r = 0.78, p < .001); subjects having the greatest increases were those who perceived the most intense high. This relationship remained significant after partialing out for dose and concentration of methylphenidate in plasma. Furthermore, subjects for whom methylphenidate did not increase dopamine did not perceive a high. These results represent the first clear demonstration that stimulant-induced high, a mood descriptor that reflects reinforcing effects of drugs in humans, is associated with increases in brain dopamine, and also that there is a quantitative relationship between levels of D2 receptor occupancy by dopamine and the intensity of the high.


0022-3565/99/2911-0409$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurosci.Home page
W. K. Schiffer, C. N. B. Liebling, C. Reiszel, J. M. Hooker, J. D. Brodie, and S. L. Dewey
Cue-Induced Dopamine Release Predicts Cocaine Preference: Positron Emission Tomography Studies in Freely Moving Rodents
J. Neurosci., May 13, 2009; 29(19): 6176 - 6185.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A H Evans, A D Lawrence, and A J Lees
Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, March 1, 2009; 80(3): 267 - 272.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
M. R.C. Daglish, T. M. Williams, S. J. Wilson, L. G. Taylor, C. B. Eap, M. Augsburger, C. Giroud, D. J. Brooks, J. S. Myles, P. Grasby, et al.
Brain dopamine response in human opioid addiction
The British Journal of Psychiatry, July 1, 2008; 193(1): 65 - 72.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
B Sessa and D Nutt
Reply to letter by Green, Marsden and Fone (2007) about Sessa and Nutt's editorial (MDMA: baby with the bath water) in the November 2007 Journal
J Psychopharmacol, June 1, 2008; 22(4): 457 - 458.
[PDF]


Home page
Theory PsychologyHome page
J. A. den Boer, A.A.T. S. Reinders, and G. Glas
Special Section: On Looking Inward: Revisiting the Role of Introspection in Neuroscientific and Psychiatric Research
Theory Psychology, June 1, 2008; 18(3): 380 - 403.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
M. R. Drew, E. H. Simpson, C. Kellendonk, W. G. Herzberg, O. Lipatova, S. Fairhurst, E. R. Kandel, C. Malapani, and P. D. Balsam
Transient Overexpression of Striatal D2 Receptors Impairs Operant Motivation and Interval Timing
J. Neurosci., July 18, 2007; 27(29): 7731 - 7739.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. D. Gray, M. Punsoni, N. E. Tabori, J. T. Melton, V. Fanslow, M. J. Ward, B. Zupan, D. Menzer, J. Rice, C. T. Drake, et al.
Methylphenidate Administration to Juvenile Rats Alters Brain Areas Involved in Cognition, Motivated Behaviors, Appetite, and Stress
J. Neurosci., July 4, 2007; 27(27): 7196 - 7207.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
H. Ashton, P. Gallagher, and B. Moore
The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder
J Psychopharmacol, September 1, 2006; 20(5): 602 - 610.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
A. L. Malizia
The role of emission tomography in pharmacokinetic and pharmacodynamic studies in clinical psychopharmacology
J Psychopharmacol, July 1, 2006; 20(4_suppl): 100 - 107.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
N. D. Volkow and J. M. Swanson
Variables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHD
Am J Psychiatry, November 1, 2003; 160(11): 1909 - 1918.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Pecina, B. Cagniard, K. C. Berridge, J. W. Aldridge, and X. Zhuang
Hyperdopaminergic Mutant Mice Have Higher "Wanting" But Not "Liking" for Sweet Rewards
J. Neurosci., October 15, 2003; 23(28): 9395 - 9402.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. Tong, B. M. Ross, G. A. Schmunk, F. J. Peretti, K. S. Kalasinsky, Y. Furukawa, L. C. Ang, S. S. Aiken, D. J. Wickham, and S. J. Kish
Decreased Striatal Dopamine D1 Receptor- Stimulated Adenylyl Cyclase Activity in Human Methamphetamine Users
Am J Psychiatry, May 1, 2003; 160(5): 896 - 903.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. A. Gusnard, J. M. Ollinger, G. L. Shulman, C. R. Cloninger, J. L. Price, D. C. Van Essen, and M. E. Raichle
Persistence and brain circuitry
PNAS, March 18, 2003; 100(6): 3479 - 3484.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. E. Kelley and K. C. Berridge
The Neuroscience of Natural Rewards: Relevance to Addictive Drugs
J. Neurosci., May 1, 2002; 22(9): 3306 - 3311.
[Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
L. K. Tremblay, C. A. Naranjo, L. Cardenas, N. Herrmann, and U. E. Busto
Probing Brain Reward System Function in Major Depressive Disorder: Altered Response to Dextroamphetamine
Arch Gen Psychiatry, May 1, 2002; 59(5): 409 - 416.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. B. Caine, S. S. Negus, N. K. Mello, S. Patel, L. Bristow, J. Kulagowski, D. Vallone, A. Saiardi, and E. Borrelli
Role of Dopamine D2-like Receptors in Cocaine Self-Administration: Studies with D2 Receptor Mutant Mice and Novel D2 Receptor Antagonists
J. Neurosci., April 1, 2002; 22(7): 2977 - 2988.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
E. M. Bednarczyk
Functional Imaging for the Monitoring of Clinical Outcomes of Pharmacotherapy
Journal of Pharmacy Practice, August 1, 2001; 14(4): 298 - 307.
[Abstract] [PDF]


Home page
FASEB J.Home page
S. JAYANTHI, X. DENG, M. BORDELON, M. T. MCCOY, and J. L. CADET
Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex
FASEB J, August 1, 2001; 15(10): 1745 - 1752.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
D. M. Tomkins and E. M. Sellers
Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence
Can. Med. Assoc. J., March 1, 2001; 164(6): 817 - 821.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. S. Gordon, L. Yao, Z. Jiang, C. S. Fishburn, S. Fuchs, and I. Diamond
Ethanol Acts Synergistically with a D2 Dopamine Agonist to Cause Translocation of Protein Kinase C
Mol. Pharmacol., January 1, 2001; 59(1): 153 - 160.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
C. L. Wyvell and K. C. Berridge
Intra-Accumbens Amphetamine Increases the Conditioned Incentive Salience of Sucrose Reward: Enhancement of Reward "Wanting" without Enhanced "Liking" or Response Reinforcement
J. Neurosci., November 1, 2000; 20(21): 8122 - 8130.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. D. Volkow, G.-J. Wang, J. S. Fowler, J. Logan, M. Gerasimov, L. Maynard, Y.-S. Ding, S. J. Gatley, A. Gifford, and D. Franceschi
Therapeutic Doses of Oral Methylphenidate Significantly Increase Extracellular Dopamine in the Human Brain
J. Neurosci., January 15, 2001; 21(2): RC121 - RC121.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Knutson, C. M. Adams, G. W. Fong, and D. Hommer
Anticipation of Increasing Monetary Reward Selectively Recruits Nucleus Accumbens
J. Neurosci., August 15, 2001; 21(16): RC159 - RC159.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.